Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

161. The effectiveness of remote access for patients with COPD: a systematic review and meta-analysis

The effectiveness of remote access for patients with COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

162. Efficacy of long-term inspiratory muscle training added to general exercise training in stable COPD patients: a meta-analysis of randomized controlled trials

Efficacy of long-term inspiratory muscle training added to general exercise training in stable COPD patients: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2018 PROSPERO

163. Effect of beta-blockers on clinical, safety and health related quality of life outcomes in patients with chronic obstructive pulmonary disease (COPD): a systematic literature review and meta-analysis with or without multiple treatment comparison

Effect of beta-blockers on clinical, safety and health related quality of life outcomes in patients with chronic obstructive pulmonary disease (COPD): a systematic literature review and meta-analysis with or without multiple treatment comparison Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content

2018 PROSPERO

164. Models of care for multi-morbidity in the UK: a mixed methods evaluation for COPD patients

Models of care for multi-morbidity in the UK: a mixed methods evaluation for COPD patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

165. Change in V?O2peakin response toaerobic training in patients with COPD: a systematic review and meta-analysis

Change in V?O2peakin response toaerobic training in patients with COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2018 PROSPERO

166. Ranking the efficacy of approved dual fixed-dose combination (FDC) therapies in chronic obstructive pulmonary disease (COPD): a network meta-analysis

Ranking the efficacy of approved dual fixed-dose combination (FDC) therapies in chronic obstructive pulmonary disease (COPD): a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

167. Vitamin D Supplementation for chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis of randomized controlled trials

Vitamin D Supplementation for chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

168. Are patient outcomes for HF and COPD better when caregivers are involved in the delivery of self-management interventions?Comparing outcomes of self-management interventions involving caregivers in the delivery with the outcomes of self-management interve

Are patient outcomes for HF and COPD better when caregivers are involved in the delivery of self-management interventions?Comparing outcomes of self-management interventions involving caregivers in the delivery with the outcomes of self-management interve Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content

2018 PROSPERO

169. Dietary risk factors for poor lung function and chronic obstructive pulmonary disease (COPD) in low and middle income countries

Dietary risk factors for poor lung function and chronic obstructive pulmonary disease (COPD) in low and middle income countries Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

170. Bacteria in the united airways of patients with chronic rhinosinusitis (CRS) and chronic obstructive pulmonary disease (COPD): protocol for a systematic review

Bacteria in the united airways of patients with chronic rhinosinusitis (CRS) and chronic obstructive pulmonary disease (COPD): protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2018 PROSPERO

171. The effects of self-management strategies on quality of life in individuals with COPD: a systematic review and meta-analysis

The effects of self-management strategies on quality of life in individuals with COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

172. Comparative safety and effectiveness of bronchodilators and inhaled corticosteroid for treating asthma-COPD overlap: a systematic review and meta-analysis

Comparative safety and effectiveness of bronchodilators and inhaled corticosteroid for treating asthma-COPD overlap: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

173. Combination therapy of phosphodiesterase 4 inhibitors for management in stable COPD patients: a meta-analysis

Combination therapy of phosphodiesterase 4 inhibitors for management in stable COPD patients: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2018 PROSPERO

174. Roflumilast (Daxas) for maintenance treatment of severe chronic obstructive lung disease (COPD)

Roflumilast (Daxas) for maintenance treatment of severe chronic obstructive lung disease (COPD) Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD) | Report | National Health Care Institute You are here: Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD) Search within English part of National Health Care Institute Search Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung (...) disease (COPD) Zorginstituut Nederland has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug currently included in the Medicine Reimbursement System (GVS). Registration Roflumilast is registered as an addition to treatment with bronchodilators for the maintenance treatment of severe chronic obstructive lung disease (COPD) associated with chronic bronchitis in adults whose COPD flares up frequently. Roflumilast is available as 500 microgram film-coated tablets

2018 National Health Care Institute (Zorginstituut Nederland)

175. Comparison of two scores of short term serious outcome in COPD patients.

Comparison of two scores of short term serious outcome in COPD patients. Chronic Obstructive Pulmonary Disease (COPD) related visits to the emergency department have increased substantially during the past decade. An important challenge facing emergency physicians when treating COPD patients is deciding on disposition. The aim of this study was to evaluate Integrated Pulmonary Index scoring to guide the disposition decisions of emergency physicians by comparing its compatibility with Ottawa (...) COPD Risk Score.This is a prospective methodological study, in which we compared the accuracies of the Integrated Pulmonary Index and Ottawa COPD Risk Score in predicting of the short-term serious outcomes in patients admitted to the emergency department with COPD exacerbation. Patients who admitted to our emergency department between 01.01.2019-31.03.2019 were evaluated.Among the 208 patients, there were 154 (74.0%) short-term serious outcomes. The AUCs were 0.915 and 0.943 for Integrated

2018 EvidenceUpdates

176. Randomised controlled trial: Non-invasive positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure

Randomised controlled trial: Non-invasive positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure Non-invasive positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You (...) positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure Article Text Adult nursing Randomised controlled trial Non-invasive positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure Magnus Ekström Statistics from Altmetric.com Commendary on: Murphy PB, Rehal S, Arbane G, et al . Effect of home

2018 Evidence-Based Nursing

177. Antiplatelet for COPD patients: a systematic review and meta-analysis

Antiplatelet for COPD patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2018 PROSPERO

178. A systematic review of antibiotics for exacerbations of chronic obstructive lung disease (COPD) in an outpatient setting

A systematic review of antibiotics for exacerbations of chronic obstructive lung disease (COPD) in an outpatient setting Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

179. Systematic literature review and network meta-analysis of clinical benefit of inhaled maintenance therapies in Chronic Obstructive Pulmonary Disease (COPD)

Systematic literature review and network meta-analysis of clinical benefit of inhaled maintenance therapies in Chronic Obstructive Pulmonary Disease (COPD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

180. Systematic review and meta-analysis of telehealth for COPD patients

Systematic review and meta-analysis of telehealth for COPD patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2018 PROSPERO